Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 1 | -$0.03 | -$0.03 | -$0.03 |
Jupiter Neurosciences, Inc. last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Jupiter Neurosciences, Inc. has generated $0 earnings per share over the last year ($-0.15 diluted earnings per share) and currently has a price-to-earnings ratio of -138. Jupiter Neurosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
12/23/2024 | Q3 2024 | -$0.02 | $0 | $0 | ||
06/30/2024 | Q2 2024 | $0.01 | $0 | |||
03/31/2024 | Q1 2024 | -$0.02 | $0 | |||
12/31/2023 | Q4 2023 | -$0.01 | $0 | |||
09/30/2023 | Q3 2023 | -$0.07 | $0 | |||
06/30/2023 | Q2 2023 | -$0.03 | $0 | |||
03/31/2023 | Q1 2023 | -$0.04 | $0 | |||
06/29/2022 | Q2 2022 | -$0.08 | $233,281 | |||
03/30/2022 | Q1 2022 | -$0.07 | $0 | |||
12/30/2021 | Q4 2021 | -$0.23 | $0 | |||
09/29/2021 | Q3 2021 | -$0.14 | $0 | |||
06/29/2021 | Q2 2021 | -$0.09 | $264,270 | |||
03/30/2021 | Q1 2021 | -$0.03 | $373,767 | |||
12/30/2020 | Q4 2020 | -$0.05 | $1.03 M | |||
09/29/2020 | Q3 2020 | -$0.06 | $101,000 |
The conference call for Jupiter Neurosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Jupiter Neurosciences, Inc.'s latest earnings report can be read online.
Jupiter Neurosciences, Inc. (:JUNS) has a recorded net income of $0. Jupiter Neurosciences, Inc. has generated $-0.15 earnings per share over the last four quarters.
Jupiter Neurosciences, Inc. (:JUNS) has a price-to-earnings ratio of -138 and price/earnings-to-growth ratio is -4.26.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED